PAIN MEDICINE

Monitoring and reporting adverse events in pragmatic clinical trials testing nonpharmacological pain management interventions
Burns A, Young-McCaughan S, Davis AF, Vining R, Ali J, Fritz JM, Morasco BJ, Rhon DI, Roogow R, Kyriakides TC and Kerns RD
Pragmatic clinical trials as hybrid effectiveness-implementation studies to shrink the evidence-to-practice gap for chronic pain management
Midboe AM, Seal KH, Burgess DJ, Rosen MI and Martino S
Do mindfulness interventions cause harm? Findings from the Learning to Apply Mindfulness to Pain (LAMP) Pragmatic Clinical Trial
Burgess DJ, Calvert C, Bangerter A, Branson M, Cross LJS, Evans R, Ferguson JE, Friedman JK, Hagel Campbell EM, Haley AC, Hennessy S, Kraft C, Mahaffey M, Matthias MS, Meis LA, Serpa JG, Taylor SL and Taylor BC
Although mindfulness-based interventions (MBIs) are widely used in clinical and nonclinical settings, there has been little systematic study of their potential risks. To address this gap, we examined differences in psychological and physical worsening among participants in the usual care and intervention conditions of a 3-group, randomized pragmatic trial (Learning to Apply Mindfulness to Pain [LAMP]) that tested the effectiveness of 2 approaches to delivering MBIs to patients with chronic pain.
Toward facilitating the collection and utilization of patient-reported outcomes in the Military Health System: Lessons learned from a pragmatic clinical trial on physical therapy management for low back pain
Beisheim-Ryan EH, Hendershot BD, Mauntel TC, Gorczynski SR, Smith RW, Crunkhorn A, Farrokhi S and Dearth CL
Tele-collaborative outreach to rural patients with chronic pain: pragmatic effectiveness trial protocol for the CORPs study
Morasco BJ, Pal N, Ono SS, McPherson SM, Lynch FL, Dickerson JF, Dobscha SK, Krebs EE, Makris UE, Mixon AS, Maloy P, Davis MM and Lovejoy TI
Despite the increased availability of evidence-based treatments for chronic pain, many patients in rural areas experience poor access to services. Patients receiving care through the VA may also need to navigate multiple systems of care.
Identifying factors associated with persistent opioid use after total joint arthroplasty: A retrospective review
Quaye A, DiPalazzo J, Kostka K, Richard JM, Beers-Mulroy B, Peck M, Krulee R and Zhang Y
To identify predictors of persistent opioid use in opioid-naïve individuals undergoing total joint arthroplasty.
How initial perceptions of the effectiveness of mind and body complementary and integrative health therapies influence long-term adherence in a pragmatic trial
Zeliadt SB, Coggeshall S, Zhang X, Rosser EW, Reed Ii DE, Elwy AR, Bokhour BG, Toyama JA and Taylor SL
Beliefs and perceptions about pain intervention effectiveness when initiating a therapy may influence long-term engagement. This study examines how early perceived effectiveness of complementary and integrative health therapies impacts long-term engagement in a pragmatic trial context.
Utility of the PICOTS framework to assess clinical trial disruptions: monitoring the impact of COVID-19 in the Pain Management Collaboratory
Peduzzi P, Brandt C, Dearth CL, Dziura J, Farrokhi S, George SZ, Kyriakides TC, Long CR, Mascha EJ, Patterson CG, Rhon DI and Kerns RD
Despite careful design of clinical trials, unforeseen disruptions can arise. The PICOTS (Patient population, Intervention, Comparator, Outcomes, Timepoints, Setting) framework was used to assess disruptions in pain management research imposed by coronavirus disease 2019 (COVID-19) within the Pain Management Collaboratory.
The Intersectionality of Chronic Pain Stigma and Racial Discrimination in Black and White Adults with Chronic Low Back Pain
Wilson JM, Booker SQ, Goodin BR, Thomas PA, Sorge RE, Quinn TL, Morris MC, Aroke EN and Meints SM
We examined the intersection between chronic pain stigma and racial discrimination, separately among Black and White U.S. adults with chronic low back pain.
The Q2-Approach for Percutaneous Peripheral Neuromodulation Stimulator Implant Targeting C2 Dorsal Root Ganglion at C2 Lamina for Treating Intractable Headache: A Technical Note
Chen Q and Qian X
Despite significant medical treatment advancements, interventional treatments for intractable headache disorders are limited. This study's objective is to detail a novel percutaneous approach ("Q2-approach") and its technical considerations for implanting peripheral neuromodulation stimulators (PNS) to the C2 dorsal root ganglion (C2-DRG) at C2 lamina, a previously unattempted target, as a treatment for intractable headache.
RE: Exploring new educational approaches in neuropathic pain: Assessing accuracy and consistency of AI responses from GPT-3.5 and GPT-4
Daungsupawong H and Wiwanitkit V
RE: Exploring new educational approaches in neuropathic pain: Assessing accuracy and consistency of AI responses from GPT-3.5 and GPT-4
García-Rudolph A, Sanchez-Pinsach D, Opisso E and Soler MD
Sociogeographic determinants of rapid opioid reduction or discontinuation among High-Dose Long-Term opioid therapy patients in North Carolina, 2006-2018
Alam IZ, DiPrete BL, Pence BW, Planey AM, Marshall SW, Fulcher N and Ranapurwala SI
Rapid opioid reduction or discontinuation among high-dose long-term opioid therapy patients (HD-LTOT) is associated with increased risk of heroin use, overdose, opioid use disorder, and mental health crises. We examined the association of residential segregation and healthcare access with rapid opioid reduction or discontinuation among HD-LTOT patients, and examined effect measure modification of individual-level characteristics.
Recommendations for monitoring adherence and fidelity in pragmatic trials based on experience in the Pain Management Collaboratory
Dziura J, Gilstad-Hayden K, Coffman CJ, Long CR, Yu Q, Buta E, Coggeshall S, Geda M, Peduzzi P and Kyriakides TC
Most pragmatic trials follow the PRagmatic Explanatory Continuum Indicator Summary (PRECIS-2) criteria. The criteria specify unobtrusive measurement of participants' protocol adherence and practitioners' intervention fidelity but suggest no special monitoring strategies to assure trial integrity. We present experience with adherence/fidelity monitoring in the Pain Management Collaboratory (PMC) and provide recommendations for their monitoring in pragmatic trials to preserve inferences of treatment comparisons.
Impact of the COVID-19 pandemic on participants in pragmatic clinical trials for chronic pain: implications for trial outcomes and beyond
Sellinger JJ, Gilstad-Hayden K, Lazar C, Seal K, Purcell N, Burgess DJ, Martino S, Heapy A, Higgins D and Rosen MI
The COVID-19 pandemic had profound effects on society, including those living with chronic pain. This study sought to examine pandemic impacts on individuals enrolled in pragmatic clinical trials focused on nonpharmacological treatments for chronic pain.
Screening, brief intervention, and referral to treatment for pain management for veterans separating from military service: study protocol of a hybrid type 2 study testing implementation facilitation versus training-as-usual
Sellinger JJ, Rosen MI, Lazar CM, Gilstad-Hayden K, Dziura J, Li FY, Mattocks K, Weede A, Sullivan-Tibbs M, Rose L, Garcia Vassallo G, Manhapra A, Turner A, Vogt D, Woodward EN, Hartmann CW, Haskell SG, Mohammad A and Martino S
Veterans transitioning to civilian life often have chronic pain from service-related musculoskeletal disorders (MSD) with higher risk for substance misuse. Many seek VA (Department of Veterans Affairs) compensation for MSD. Use of Screening, Brief Intervention, and Referral to Treatment for Pain Management (SBIRT-PM) by VA Post-9/11 Military2VA (M2VA) case managers presents an opportunity to engage these veterans in VA pain care and address substance misuse. Implementation facilitation might help case managers use SBIRT-PM and engage veterans in services to improve outcomes.
Perspectives on pain management from the veterans health administration and the defense health agency
Kligler B, Teyhen D and Cordts P
Achieving two-part harmony: standardizing pain-related phenotypes and outcomes
Edwards R, Geda M, Burgess DJ, Davis AF, DeBar L, Pal N, Peduzzi P, Taylor SL, Wallace R and Luther SL
Strategies for working with pragmatic clinical trial observational data-lessons learned from the Pain Management Collaboratory
Matheny ME, Brandt C, Jannace KC, Roddy WT, Raffanello M, Silliker N and Erdos J
The implementation of a pain navigator program in the department of Veterans Affairs' (VA) health care systems: a cluster randomized pragmatic clinical trial
France C, Cook CE, Coffman CJ, Tumminello C, Choate A, George SZ, Lentz TA and Hastings SN
This manuscript describes the uptake of the AIM-Back Pain Navigator Pathway (PNP) designed to encourage use of non-pharmacologic care options within the Veterans Health Administration (VHA).
Proinflammatory Diet is Associated with Higher Pain, Disease Severity and Biochemical Parameters Associated with Inflammation in Fibromyalgia
Ersoy Söke N, İnceöz H, Solmaz İ and Yardımcı H
Fibromyalgia, which is becoming increasingly common today, affects the quality of life of those affected. The aim of this study was to investigate the relationship between diet and pain, disease severity and biochemical parameters in fibromyalgia.